Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

09 Sep 2022 Evaluate

Zydus Lifesciences has informed that it enclosed copy of press release dated September 9, 2022 titled ‘Zydus in-licenses a critical drug for CKD patients from Pharmacosmos A/S of Denmark’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1915.10
Dr. Reddys Labs. 1369.00
Cipla 1410.95
Lupin 1995.00
Zydus Lifesciences 1200.00
View more..